Skip to Content

LCE 150 (Stalevo 150 37.5 mg / 200 mg / 150 mg)

Generic Name: carbidopa/entacapone/levodopa

Pill with imprint LCE 150 is Brown, Elliptical / Oval and has been identified as Stalevo 150 37.5 mg / 200 mg / 150 mg. It is supplied by Novartis Pharmaceuticals.

Stalevo 150 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 150 37.5 mg / 200 mg / 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 150

Stalevo 150

Generic Name:
LCE 150
37.5 mg / 200 mg / 150 mg
15.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Novartis Pharmaceuticals
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00078-0409 Novartis Pharmaceuticals Corporation
00781-5654 Sandoz Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.